Yolanda Bravo Vergel

Summary

Affiliation: University of York
Country: UK

Publications

  1. ncbi request reprint Difficult commissioning choices: lessons from English primary care trusts
    Yolanda Bravo Vergel
    Centre for Health Economics, University of York, York, UK
    J Health Serv Res Policy 11:150-4. 2006
  2. ncbi request reprint The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis
    Y Bravo Vergel
    Centre for Health Economics, University of York, Heslington, YO10 5DD York, UK
    Rheumatology (Oxford) 46:1729-35. 2007
  3. ncbi request reprint Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
    N Woolacott
    Centre for Reviews and Dissemination, University of York, UK
    Health Technol Assess 10:iii-iv, xiii-xvi, 1-239. 2006
  4. ncbi request reprint A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder
    K Soares-Weiser
    Centre for Reviews and Dissemination, University of York, UK
    Health Technol Assess 11:iii-iv, ix-206. 2007
  5. ncbi request reprint Making decisions under uncertainty--the role of probabilistic decision modelling
    Yolanda Bravo Vergel
    Centre for Health Economics, University of York, York YO10 5DD, UK
    Fam Pract 23:391-2. 2006
  6. pmc Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis
    Yolanda Bravo Vergel
    Centre for Health Economics, University of York, York, UK
    Heart 93:1238-43. 2007

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Difficult commissioning choices: lessons from English primary care trusts
    Yolanda Bravo Vergel
    Centre for Health Economics, University of York, York, UK
    J Health Serv Res Policy 11:150-4. 2006
    ..Our objective was to describe recent local developments on prioritization decision-making...
  2. ncbi request reprint The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis
    Y Bravo Vergel
    Centre for Health Economics, University of York, Heslington, YO10 5DD York, UK
    Rheumatology (Oxford) 46:1729-35. 2007
    ..We assess the cost-effectiveness of two TNF antagonists and so-called 'palliative care' for the treatment of active PsA from the perspective of the UK National Health Service (NHS)...
  3. ncbi request reprint Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
    N Woolacott
    Centre for Reviews and Dissemination, University of York, UK
    Health Technol Assess 10:iii-iv, xiii-xvi, 1-239. 2006
    ....
  4. ncbi request reprint A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder
    K Soares-Weiser
    Centre for Reviews and Dissemination, University of York, UK
    Health Technol Assess 11:iii-iv, ix-206. 2007
    ..To determine the clinical effectiveness and cost-effectiveness of pharmacological and/or psychosocial interventions for the prevention of relapse in people with bipolar disorder...
  5. ncbi request reprint Making decisions under uncertainty--the role of probabilistic decision modelling
    Yolanda Bravo Vergel
    Centre for Health Economics, University of York, York YO10 5DD, UK
    Fam Pract 23:391-2. 2006
  6. pmc Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis
    Yolanda Bravo Vergel
    Centre for Health Economics, University of York, York, UK
    Heart 93:1238-43. 2007
    ..To assess the cost effectiveness of primary angioplasty, compared with medical management with thrombolytic drugs, to achieve reperfusion after acute myocardial infarction (AMI) from the perspective of the UK NHS...